Makarand Jawadekar

Currently an independent Pharmaceutical Professional, Dr. Jawadekar worked at Pfizer, Inc. for 28 consecutive years. He worked as a Director, Portfolio Management, was responsible for Drug Delivery Technology Assessment where developed extensive experience creating and cultivating external partnerships and alliances for drug delivery technologies. He began his carreer at Pfizer Centeral Research in 1982 after having ocmpleted his PhD. In Pharmeuetics at the University of Minnesota. Dr. Jawadekar was honored with an honorary D.Sc. degree by DYP Mumbai Univeristy, recommended by the President of India in 2011.

His experience with Pfizer R&D includes Solids R&D, Drug Product formulation/Dosage Form/Drug Delivery development, Clinical Trials Supply Manufacturing, Scale-up and Technology Transfer, Pharma R&D outsourcing, as well as Pharmacy areas. He managed several functions/groups within R&D and was the Bench Scientist who worked on the challenging Sertraline (ZOLOFT) tablets formulation which became a multibillion dollar product for many years for Pfizer, Inc. He was the recipient of the "M.L. Khorana Memorial Lecture of the Year Award" at IPC held in New Delhi, India, in 2001. He was invited to join President George W. Bush's trade delegation to India during March 2006 and traveled to India with Pfizer Global R&D President Dr. John LaMattina during 2007 to visit 8 cities in India to view and assess the Pharmaceutical R&D landscape. Dr. Jawakadar represented Pfizer at BioAsia 2009 with Pfizer R&D President, Dr. Martin Mackay in 2009 and served as a Vice President of Asia Pacific American Colleague Resource Group at Pfizer for many years.